Amanote Research
Register
Sign In
P2.01-101 Dynamic Monitoring of Gene Alterations With ctDNA by NGS for EGFR Mutated Lung Adenocarcinoma Treated With Gefitinib in BENEFIT Study (CTONG 1405)
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1156
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
J. Duan
S. Wang
Z. Wang
H. Bai
J. Zhao
H. Gao
Y. Cheng
J. Wang
Publisher
Elsevier BV
Related search
P2.01-125 EGFR Mutations by NGS in Advanced Squamous Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.03-030 Cumulative Smoking Dose Affects the Clinical Outcomes of EGFR-Mutated Lung Adenocarcinoma Patients Treated With EGFR-TKIs
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.01-78 Validation of InVisionFirst ctDNA NGS Profiling via ddPCR Testing in Patients With Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Identification of Transcriptional Subgroups in EGFR-Mutated and EGFR/KRAS Wild-Type Lung Adenocarcinoma Reveals Gene Signatures Associated With Patient Outcome
Clinical Cancer Research
Cancer Research
Oncology
EGFR Mutation, but Not Sex and Smoking, Is Independently Associated With Favorable Prognosis of Gefitinib-Treated Patients With Lung Adenocarcinoma
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
P2.01-06 HSP72 Expression Associates With Survival in EGFR Mutated NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Mutation Profile of Resected EGFR‐Mutated Lung Adenocarcinoma by Next‐Generation Sequencing
Oncologist
Cancer Research
Medicine
Oncology
P2.01-107 Analysis of Mutation Detection by ctDNA on the Basis of Metastatic Sites in Lung Adenocarcinoma Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Risk Factors of Brain Metastasis During the Course of EGFR-TKIs Therapy for Patients With EGFR-mutated Advanced Lung Adenocarcinoma
Oncotarget
Oncology